Bicocca Open Archive

Logo unimib boa
SQUILLACE, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.384
EU - Europa 1.775
AS - Asia 801
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
AF - Africa 2
Totale 5.983
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.328
IT - Italia 433
DE - Germania 343
SE - Svezia 269
IE - Irlanda 252
SG - Singapore 252
CN - Cina 211
RU - Federazione Russa 181
HK - Hong Kong 109
ID - Indonesia 101
GB - Regno Unito 77
VN - Vietnam 64
UA - Ucraina 57
CA - Canada 55
DK - Danimarca 41
FI - Finlandia 33
IN - India 31
NL - Olanda 18
BE - Belgio 15
FR - Francia 12
AT - Austria 9
TR - Turchia 8
CH - Svizzera 7
PL - Polonia 7
CO - Colombia 6
CZ - Repubblica Ceca 4
IR - Iran 4
JP - Giappone 4
ES - Italia 3
EU - Europa 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
BR - Brasile 2
BY - Bielorussia 2
CL - Cile 2
LT - Lituania 2
LU - Lussemburgo 2
MM - Myanmar 2
PE - Perù 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BS - Bahamas 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
KR - Corea 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 5.983
Salva come PNG Salva come JPEG
Città #
Ann Arbor 926
Frankfurt am Main 282
Fairfield 281
Dublin 243
Chandler 240
New York 226
Singapore 212
Wilmington 193
Ashburn 149
Woodbridge 142
Houston 132
Hong Kong 109
Seattle 103
Jakarta 101
Santa Clara 96
Princeton 91
Milan 78
Cambridge 75
Dearborn 56
Jacksonville 50
Dong Ket 41
Lawrence 41
Altamura 38
Shanghai 38
Nanjing 28
Guangzhou 25
London 24
San Diego 24
Ottawa 23
Helsinki 20
Beijing 19
Rome 19
Fremont 18
Los Angeles 16
Andover 14
Brussels 14
Falls Church 13
Boardman 11
Monza 11
Pune 10
Toronto 10
Lachine 9
Nanchang 9
Edmonton 8
Shenyang 8
Turin 8
Carate Brianza 7
Hangzhou 7
Jinan 7
Munich 7
Palermo 7
Casorate Primo 6
Naples 6
Vienna 6
Zurich 6
Acquafredda 5
Amsterdam 5
Bogotá 5
Bresso 5
Changsha 5
Florence 5
Gallarate 5
Kiev 5
Washington 5
Casier 4
Edinburgh 4
Hanoi 4
Hebei 4
Kunming 4
Lissone 4
Paris 4
Perugia 4
Polska 4
San Francisco 4
Tianjin 4
Auckland 3
Bangkok 3
Cork 3
Frattamaggiore 3
Genoa 3
Genova 3
Glasgow 3
Kilburn 3
Lappeenranta 3
Leawood 3
Maastricht 3
Mariano Comense 3
Muggiò 3
Norwalk 3
Pioltello 3
Romola 3
Shenzhen 3
Stockholm 3
Tokyo 3
Zhengzhou 3
Albano Sant'Alessandro 2
Atlanta 2
Bangalore 2
Bari 2
Bhubaneswar 2
Totale 4.502
Salva come PNG Salva come JPEG
Nome #
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 234
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 218
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 212
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 203
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare 189
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 186
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 185
Brachial and central blood pressure in HIV-infected subjects 180
Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated with the Evolution of Cognitive Performance in HIV-Infected Patients 176
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 174
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 169
Unmasking tuberculosis in the era of antiretroviral treatment 167
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 165
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 165
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 163
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances 162
Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? 157
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 136
The role for tocilizumab in covid-19 patients: Reflections on monza cohort data 131
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 130
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 111
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible from the STOPSHIV Project Cohort 109
Weight gain: A possible side effect of all antiretrovirals 107
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 102
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 99
Arterial structure and function in AIDS patients: the impact of renal damage. 98
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 98
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 98
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 97
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 95
A multidisciplinary approach to screen the post-COVID-19 conditions 92
Factors Associated With Weight Gain in People Treated With Dolutegravir 92
Invecchiare con la terapia antiretrovirale o essere anziani in terapia antiretrovirale: due profili di comorbidità differenti? 91
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 90
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 88
Factors associated with hospital admission for COVID-19 in HIV patients 88
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 87
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 81
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 78
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project 77
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 74
Arterial structural and functional effects of two different antiretroviral therapy protocol on naïve HIV-infected subjects 72
Early changes in adhesion molecules expression and endothelial function in patients initiating ART with Atazanavir or Lopinavir 71
Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19? 68
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 66
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 65
Fattori associati con il ricovero ospedaliero per COVID-19 in 80 pazienti HIV-positivi italiani. Factors associated with hospital admission for COVID-19 in 80 Italian HIV patients. 58
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile 58
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 52
Reversibility of Central Nervous System Adverse Events in Course of Art 47
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 46
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 44
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study 41
HIV and SARS-CoV-2 Co-Infection: What are the Risks? 40
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens 39
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? 38
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda 31
Incident diabetes in course of antiretroviral therapy 30
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 23
Totale 6.343
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020438 0 0 0 0 0 0 60 58 76 72 84 88
2020/20211.293 54 78 101 117 99 175 126 139 94 117 61 132
2021/2022692 75 63 82 61 19 48 18 34 18 60 68 146
2022/20231.272 135 346 108 104 67 193 23 103 84 21 50 38
2023/20241.037 51 18 69 29 119 315 165 48 83 27 7 106
2024/2025845 92 219 107 116 175 135 1 0 0 0 0 0
Totale 6.343